Ally Bridge Group (Ny) LLC Tarsus Pharmaceuticals, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $69.6 Million
- Q2 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 121,182 shares of TARS stock, worth $8.38 Million. This represents 7.05% of its overall portfolio holdings.
Number of Shares
121,182
Previous 127,932
5.28%
Holding current value
$8.38 Million
Previous $6.57 Million
25.29%
% of portfolio
7.05%
Previous 8.64%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
215Shares Held
46.5MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$226 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$215 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$206 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$171 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$170 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.84B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...